The pharmacokinetic profile with the therapeutic dose assortment in people really should be established, as scientific studies with rodents show that better doses lead to non-linear PK profile, and subjective outcomes at increased doses may well rely on the CYP2D6 genotype.The preparation the majority of people use for this is termed pharmahuasca.